CloudLeap Technologies, LLC., and DRT Strategies have been recognized as “Top Performer” by the U.S. Food and Drug Administration (FDA) Office of Digital Transformation (ODT) in the precisionFDA Automated Machine Learning (AutoML) App-a-thon: Democratizing and Demystifying Artificial Intelligence (AI). The goal of the App-a-thon was to assess the effectiveness of open-source AutoML tools when applied to biomedical datasets. This initiative directly aligns with the new executive order calling for government agencies to leverage AI for good, and the results will contribute to the advancement of regulatory science by evaluating how AutoML can enhance the performance of biomedical applications. You can check out the App-a-thon results here: https://lnkd.in/e-hi8_wN Our team is thrilled to have explored open-source AutoML tools and assessed their effectiveness. We aim to determine whether AutoML can match or surpass the performance of traditional ML models using biomedical datasets. We take pride in contributing to a project that not only pushes technological boundaries but also has the potential to save lives. Want to explore partnership opportunities for your next Big Data, ML, and AI project?
Not Yet a Premium Partner/Sponsor? Learn more about the OS AI Premium Corporate and Individual Plans here. Plans start at $250 annually.
